As an example and providing supporting evidence for the value of CAR‐Tregs as a therapeutic option for the treatment of colitis Blat et al. [71] demonstrated the efficacy of carcinoembryonic antigen (CEA) specific CAR Tregs in a CEA transgenic mice, using two disease models of colitis. Here, CEACAM5 is linked to colitis.